Cryosite Ltd is a leading company that values integrity, reliability, and innovation. With a strong corporate philosophy focused on providing premium services and solutions in the field of biobanking and reproductive services, Cryosite is committed to excellence. The company strives to ensure the utmost trust and transparency in all its operations, delivering high-quality cryopreservation services, cord blood banking, and stem cell research facilities. Cryosite Ltd continuously pushes boundaries through cutting-edge technology and strategic partnerships, aiming to meet the evolving needs of its customers and make a positive impact in the healthcare industry.

Cryosite Ltd primarily operates in Australia and New Zealand.

Cryosite Ltd has achieved several significant milestones. Firstly, the company successfully established itself as a leading provider of comprehensive storage solutions for stem cells, reproductive tissues, and cord blood in Australia. Additionally, Cryosite Ltd expanded its services by offering advanced cryopreservation techniques, ensuring the long-term viability of stored materials. The company's commitment to quality led to accreditation by the Therapeutic Goods Administration (TGA) and attainment of ISO 9001 certification. Furthermore, Cryosite Ltd expanded its client base, attracting partnerships with major healthcare institutions and research organizations. These milestones demonstrate Cryosite Ltd's success in delivering trusted and state-of-the-art cryogenic storage services to its clients.

Cryosite Ltd, a reputable Australian company, has an intriguing history and background. Established in 2000, Cryosite has played a pivotal role in the field of biomedical services. The company specializes in secure storage and transportation of precious biological samples, supporting medical research, clinical trials, and stem cell transplant programs. With state-of-the-art facilities and stringent quality control measures, Cryosite has gained recognition as a trusted partner for numerous healthcare institutions and research organizations globally. Over the years, Cryosite Ltd has showcased its expertise in preserving and managing these life-changing resources, contributing significantly to advancements in healthcare and cutting-edge research.

The main competitors of Cryosite Ltd in the market are companies like Stemlife, Singapore Cord Blood Bank, and CordLife Group Limited.

Cryosite Ltd is primarily active in the biomedical and life sciences industries.

The business model of Cryosite Ltd focuses on providing biobanking and cell therapy services. Cryosite specializes in the collection, storage, and distribution of human biological samples such as cord blood, tissue, and cells for medical and research purposes. The company allows individuals and families to preserve cord blood stem cells for potential future use in regenerative medicine. Cryosite also offers cell therapy manufacturing services to support personalized medicine and clinical trials. With its expertise and advanced technology, Cryosite aims to contribute to advancements in medical treatments and research, offering peace of mind to those seeking to preserve their biological materials.

Poměr Cryosite P/E je 23,34.

Koeficient Cryosite tržních hodnot je 3,41.

AlleAktien kvalitní skóre pro Cryosite je 5/10.

Cryosite obrat je 12,61 mil. AUD.

Cryosite zisk je 1,84 mil. AUD.

Cryosite Ltd is an Australian company that has been operating in the field of biological material storage for over 15 years. With a wide range of services and products, the company has established itself as a leading provider of cryo-storage solutions in Australia.

Cryosite vyplácí dividendu ve výši 0,01 AUD rozdělenou do výplat během roku.

Dividenda pro Cryosite momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti Cryosite je AU000000CTE1.

WKN společnosti Cryosite je 621943.

Ticker společnosti Cryosite je CTE.AX.

Během posledních 12 měsíců vyplatila společnost Cryosite dividendu ve výši 0,07 AUD . To odpovídá dividendovému výnosu přibližně 7,95 %. Pro nadcházejících 12 měsíců se očekává, že Cryosite vyplatí dividendu ve výši 0,07 AUD.

Výnos z dividend společnosti Cryosite aktuálně činí 7,95 %.

Cryosite vyplácí čtvrtletní dividendu. Ta je distribuována v měsících říjen, říjen, březen, říjen.

Cryosite vyplácela v posledních 3 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0,07 AUD. To odpovídá dividendovému výnosu 7,95 %.

Cryosite je přiřazen k sektoru 'Zdraví'.

Aby ses mohl podílet na poslední dividendě Cryosite ve výši 0,02 AUD, zaznamenané 10. 10. 2024, měl jsi mít akcii ve svém portfoliu před ex-dnem 6. 9. 2024.

Poslední dividendy byly vyplaceny dne 10. 10. 2024.

V roce 2023 společností Cryosite bylo vyplaceno 0,015 AUD ve formě dividend.

Dividendy společnosti Cryosite jsou vypláceny v AUD.